SOTAC PHARMACEUTICALS
Back to Income Statement
|
SOTAC PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹5.77 Cr | ₹8.03 Cr | ₹4.28 Cr | ₹2.88 Cr | ₹2.88 Cr |
What is the latest Consolidated Net Profit of SOTAC PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹5.77 Cr |
| Mar2025 | ₹8.03 Cr |
| Mar2024 | ₹4.28 Cr |
| Mar2023 | ₹2.88 Cr |
| Mar2022 | ₹2.88 Cr |
How is Consolidated Net Profit of SOTAC PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹5.77 Cr | -28.15 | |
| Mar2025 | ₹8.03 Cr | 87.50 | |
| Mar2024 | ₹4.28 Cr | 48.65 | |
| Mar2023 | ₹2.88 Cr | 0.03 | |
| Mar2022 | ₹2.88 Cr | - | |
Compare Consolidated Net Profit of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹102.1 Cr | 0.1% | -13.2% | -25% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,831.0 Cr | -0.4% | -6.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹242,074.0 Cr | 0.9% | -3.3% | 39.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,355.0 Cr | 0.1% | -7.2% | 28.2% | Stock Analytics | |
| CIPLA | ₹107,439.0 Cr | -0.3% | -4% | -15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,417.0 Cr | 1.5% | 3.1% | 0.4% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | 0.1% |
-13.2% |
-25% |
| SENSEX | 0.6% |
-1.4% |
-10.7% |
You may also like the below Video Courses